Effects of Oral Glucose and Teduglutide on Plasma Lipoproteins
Clinical trial NCT03860688 · UNKNOWN
Trial details
- NCT number
- NCT03860688
- Sponsor
- University Health Network, Toronto
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-01
- Primary completion
- 2021-12-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.